September 2025 ZOHU Call/Webinar

Aug. 26, 2025

The webcast course is open for the September 3^rd ZOHU Call webinar.
The registration code is: ZOHUwebcast.
A video recording will be posted within 30 days after the call.

1 hour

Sep 3, 2025

Webinar details

Presentation topics

Extensively drug-resistant Campylobacter jejuni linked to pet store puppies
New World Screwworm Updates

Subscribe to our newsletter

Get email updates about upcoming webinars and recordings.

Featuring

Louise Francois Watkins, MD, MPH | Presenter

Medical Officer

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention

hvu9@cdc.gov

Sean Stapleton, DVM, MPH | Presenter

Veterinary Epidemiologist

Outbreak Response and Prevention Branch, Centers for Disease Control and Prevention

Qbs1@cdc.gov

Rosemary B. Sifford, DVM | Presenter

Deputy Administrator

Animal and Plant Health Inspection Service: Veterinary Services, U.S. Department of Agriculture

Rosemary.sifford@usda.gov

Anne Straily, DVM, MPH, DACVPM | Presenter

Veterinary Medical Officer

Centers for Disease Control and Prevention

Yzv2@cdc.gov

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Webcast (Live)

Course Name: WC4565R-090325

Registration Code: ZOHUwebcast

Start Date: September 3, 2025

End Date: October 6, 2025

Web-on-Demand (Recording)

Course Name: WD4565R-090325

Start Date: October 7, 2025

End Date: October 7, 2027

Objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.